American Journal of Obstetrics and Gynecology
General obstetrics and gynecologySafety of metronidazole in pregnancy: A meta-analysis
References (22)
- et al.
Trichomoniasis: trends in diagnosis and management
Am J Obstet Gynecol
(1991) - et al.
Trichomonas vaginalis. V. Further observations on metronidazole (including infant follow-up)
Am J Obstet Gynecol
(1965) - et al.
Metronidazole in pregnancy
Am J Obstet Gynecol
(1966) Placental transfer of metronidazole in the first trimester of pregnancy
J Perinat Med
(1984)A critical appraisal of the toxicology of metronidazole
- et al.
Lack of evidence for cancer due to use of metronidazole
N Engl J Med
(1979) - et al.
Midline facial defect as a teratogenic effect of metronidazole
Birth Defects
(1982) Possible metronidazole teratogenicity and clefting
Am J Med Genet
(1985)- et al.
Metronidazole and pregnancy
Ugeskri Laeger
(1972) Innocuité du métronidazole prescrit pendant la grossesse
Med Maladie Infect
(1983)
Chemically induced birth defects
Cited by (276)
Fertility and Pregnancy in Crohn's Disease
2022, Gastroenterology Clinics of North AmericaCitation Excerpt :Fluoroquinolones have a theoretic risk of causing cartilage damage and arthropathies in the fetus when taken during pregnancy based on animal studies; however, subsequent meta-analyses do not support these findings.62,66 Short courses of nitroimidazoles seem to be safe for the mother and infant.67 Women who are taking thiopurines before conception to maintain remission can safely continue their use throughout pregnancy.
Investigating the efficacy and safety of metronidazole during pregnancy; A systematic review and meta-analysis
2021, European Journal of Obstetrics and Gynecology and Reproductive Biology: XCitation Excerpt :Moreover, the robustness of our results was proved using sensitivity analyses that produced findings similar to the original analyses. Compared to two previous meta-analyses of 1995 [20] (7 studies) and 1997 [21] (5 studies) on malformations, our meta-analysis is an update of 12 studies with 411,380 participants. Furthermore, this is the first meta-analysis to consider the assessment of risks related to MET exposure in light of the dose, duration, route of administration, indication and the period of exposure of the treatment.
Gastrointestinal disorders
2021, Clinical Pharmacology During PregnancyBacterial vaginosis in pregnancy – a storm in the cup of tea
2020, European Journal of Obstetrics and Gynecology and Reproductive BiologyPharmacotherapy during Pregnancy: An Endodontic Perspective
2020, Journal of EndodonticsMaxillofacial trauma in a pregnant patient: Contemporary management principles with a case report & review of literature
2020, Chinese Journal of Traumatology - English Edition
- 1
Dr. Burtin was supported by a grant from the Association Française pour la Recherche Thérapeutique, Paris, France
- 2
Dr. Koren is a Career Scientist of the Ontario Ministry of Health.